These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17912241)

  • 1. Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patients.
    Hurst NG; Stocken DD; Wilson S; Keh C; Wakelam MJ; Ismail T
    Br J Cancer; 2007 Oct; 97(7):971-7. PubMed ID: 17912241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma matrix metalloproteinase 9 as an early surrogate biomarker of advanced colorectal neoplasia.
    Gimeno-García AZ; Triñanes J; Quintero E; Salido E; Nicolás-Pérez D; Adrián-de-Ganzo Z; Alarcón-Fernández O; Abrante B; Romero R; Carrillo M; Ramos L; Alonso I; Ortega J; Jiménez A
    Gastroenterol Hepatol; 2016; 39(7):433-41. PubMed ID: 26601990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum S100A6, S100A8, S100A9 and S100A11 proteins in colorectal neoplasia: results of a single centre prospective study.
    Moravkova P; Kohoutova D; Vavrova J; Bures J
    Scand J Clin Lab Invest; 2020 May; 80(3):173-178. PubMed ID: 31856598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the accuracy of serum MMP-9 as a test for colorectal cancer in a primary care population.
    Wilson S; Wakelam MJ; Hobbs RF; Ryan AV; Dunn JA; Redman VD; Patrick F; Colbourne L; Martin A; Ismail T
    BMC Cancer; 2006 Oct; 6():258. PubMed ID: 17076885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum matrix metalloproteinase 9 and colorectal neoplasia: a community-based evaluation of a potential diagnostic test.
    Wilson S; Damery S; Stocken DD; Dowswell G; Holder R; Ward ST; Redman V; Wakelam MJ; James J; Hobbs FD; Ismail T
    Br J Cancer; 2012 Apr; 106(8):1431-8. PubMed ID: 22433968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum matrix metalloproteinase-9 in colorectal cancer family-risk population screening.
    Otero-Estévez O; De Chiara L; Rodríguez-Girondo M; Rodríguez-Berrocal FJ; Cubiella J; Castro I; Hernández V; Martínez-Zorzano VS
    Sci Rep; 2015 Aug; 5():13030. PubMed ID: 26264519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Behavior of MMP-2, MMP-7, MMP-9, and Their Inhibitors TIMP-1 and TIMP-2 in Adenoma-Colorectal Cancer Sequence.
    Barabás L; Hritz I; István G; Tulassay Z; Herszényi L
    Dig Dis; 2021; 39(3):217-224. PubMed ID: 32961536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the value of matrix metalloproteinase 9 (MMP9) in improving the appropriateness of referrals for colorectal cancer.
    Damery S; Nichols L; Holder R; Ward ST; Warmington S; Wilson S; Wakelam MJ; James J; Ismail T
    Br J Cancer; 2013 Mar; 108(5):1149-56. PubMed ID: 23392084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study on faecal MMP-9: a new noninvasive diagnostic marker of colorectal cancer.
    Annaházi A; Ábrahám S; Farkas K; Rosztóczy A; Inczefi O; Földesi I; Szűcs M; Rutka M; Theodorou V; Eutamene H; Bueno L; Lázár G; Wittmann T; Molnár T; Róka R
    Br J Cancer; 2016 Mar; 114(7):787-92. PubMed ID: 26908323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between the serum levels of matrix metalloproteinase 9 and colorectal cancer.
    Rašić I; Rašić A; Akšamija G; Radović S; Šehović N
    Med Glas (Zenica); 2017 Aug; 14(2):229-235. PubMed ID: 28644426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated serum matrix metalloproteinase 9 concentration predicts the presence of colorectal neoplasia in symptomatic patients.
    Belobrajdic DP; Cosgrove LJ; Phatak A
    Br J Cancer; 2008 May; 98(9):1593; author reply 1594. PubMed ID: 18414416
    [No Abstract]   [Full Text] [Related]  

  • 12. High Expression of MMP-9 in Primary Tumors and High Preoperative MPO in Serum Predict Improved Prognosis in Colorectal Cancer with Operable Liver Metastases.
    Peltonen R; Hagström J; Tervahartiala T; Sorsa T; Haglund C; Isoniemi H
    Oncology; 2021; 99(3):144-160. PubMed ID: 33027796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma.
    Tibble J; Sigthorsson G; Foster R; Sherwood R; Fagerhol M; Bjarnason I
    Gut; 2001 Sep; 49(3):402-8. PubMed ID: 11511563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of colorectal neoplasia: Combination of eight blood-based, cancer-associated protein biomarkers.
    Wilhelmsen M; Christensen IJ; Rasmussen L; Jørgensen LN; Madsen MR; Vilandt J; Hillig T; Klaerke M; Nielsen KT; Laurberg S; Brünner N; Gawel S; Yang X; Davis G; Heijboer A; Martens F; Nielsen HJ
    Int J Cancer; 2017 Mar; 140(6):1436-1446. PubMed ID: 27935033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive and prognostic value of Matrix metalloproteinase (MMP) - 9 in neoadjuvant chemotherapy for triple-negative breast cancer patients.
    Wang RX; Chen S; Huang L; Shao ZM
    BMC Cancer; 2018 Sep; 18(1):909. PubMed ID: 30241470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishing the added benefit of measuring MMP9 in FOB positive patients as a part of the Wolverhampton colorectal cancer screening programme.
    Wilson S; Taskila T; Ismail T; Stocken DD; Martin A; Redman V; Wakelam M; Perry I; Hobbs R
    BMC Cancer; 2009 Jan; 9():36. PubMed ID: 19175925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum triglyceride predicts recurrence of colorectal polyps in patients with advanced adenomas.
    Liu B; Wen P; Gu X; Weng R; Liu S
    Lipids Health Dis; 2020 Sep; 19(1):211. PubMed ID: 32967679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased serological, cancer-associated protein biomarker levels at diagnosis of large bowel adenoma: Risk of subsequent primary malignancy?
    Piper TB; Jørgensen LN; Olsen J; Nielsen KT; Davis G; Johansen JS; Jarle Christensen I; Nielsen HJ
    Acta Oncol; 2019; 58(sup1):S42-S48. PubMed ID: 30523734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of colon cancer-specific antigen 2 as a potential serum marker for colorectal cancer.
    Leman ES; Schoen RE; Magheli A; Sokoll LJ; Chan DW; Getzenberg RH
    Clin Cancer Res; 2008 Mar; 14(5):1349-54. PubMed ID: 18316554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased serum levels of complement C3a anaphylatoxin indicate the presence of colorectal tumors.
    Habermann JK; Roblick UJ; Luke BT; Prieto DA; Finlay WJ; Podust VN; Roman JM; Oevermann E; Schiedeck T; Homann N; Duchrow M; Conrads TP; Veenstra TD; Burt SK; Bruch HP; Auer G; Ried T
    Gastroenterology; 2006 Oct; 131(4):1020-9; quiz 1284. PubMed ID: 17030172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.